Zenosense Inc.

Zenosense Inc.
Stock Exchange Other OTC
EPS
$0.02
Market Cap
$2.48 M
Shares Outstanding
31.07 M
Public Float
17.44 M

Profile

Address
Avenida Cortes Valencianas 58
Valencia Valencia 46015
Spain
Employees -
Website http://zenosense.net
Updated 07/08/2019
Zenosense, Inc. engages in developing medical devices. It includes the detection of the Methicillin-resistant Staphylococcus aureus. The firm uses Acute Myocardial Infarction, and MIDS Cardiac technologies.

Financials

View All

Carlos Jose Gil
President, CEO, CFO, Secretary & Treasurer
Carlos Jose Gil
President, CEO, CFO, Secretary & Treasurer